FDA product code QXZ: Adjunctive Epicardial Vascular Physiologic Status Indicator

QXZ is the FDA product code for adjunctive epicardial vascular physiologic status indicator. It is a Class II device, regulated under 21 CFR 870.2200 and reviewed by the Cardiovascular panel. FDA has cleared 2 510(k) submissions under QXZ, 2 in the last five years. The average 510(k) review took 101 days (median 101); 79 days on average over the last three years.

Definition

The adjunctive epicardial vascular physiologic status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting the possible presence of functionally significant coronary artery disease to suggest the need for further testing. This device is intended for adjunctive use with other clinical workup or patient information and is not intended to quantify the degree to which epicardial disease is limiting flow through a vessel nor is it intended to independently direct therapy.

Classification

FieldValue
Device nameAdjunctive Epicardial Vascular Physiologic Status Indicator
Device classClass II
Regulation21 CFR 870.2200
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for QXZ

YearClearancesAvg. review days
20231123
2026179

Compare with all 510(k) review times · Search every QXZ clearance

Top QXZ applicants

ApplicantClearancesLatest
Cleerly, Inc.22026-10-29

Most recent QXZ clearances

510(k)ApplicantDeviceDecision dateReview days
K262839Cleerly, Inc.Cleerly ISCHEMIA2026-10-2979
K231335Cleerly, Inc.Cleerly ISCHEMIA2023-09-08123

Recalls for QXZ devices

FDA recall records list no recalls for product code QXZ.

Frequently asked questions

What is FDA product code QXZ?

QXZ is the FDA product code for adjunctive epicardial vascular physiologic status indicator. It is a Class II device, regulated under 21 CFR 870.2200 and reviewed by the Cardiovascular panel.

What device class is QXZ?

Class II, regulation 21 CFR 870.2200. Typical premarket route: 510(k).

How long does a 510(k) take for product code QXZ?

Across 2 cleared submissions the average was 101 days from receipt to decision (median 101).

Which companies have the most QXZ clearances?

Cleerly, Inc. (2).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times